The next generation biopharmaceuticals

Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platform:

Affibody® molecules and Albumod®

Calendar Upcoming reports & events


20 Apr

Annual Report 2022


23 May

AGM Annual General Meeting 2023

There are currently no posts in the reports and events archive.

About Affibody Further Information

Projects Affibody's pipeline

Affibody has a broad pipeline with the most advanced projects in clinical studies. The pipeline is designed to demonstrate the value and versatility of the Affibody® technology.


Career Work at Affibody

It is the competence and the engagement of all coworkers that make Affibody an inspiring and exciting place to work at. We know we reach much further in innovation, efficiency and quality by having a work place where we as coworkers care for each other, are ambitious and know and value our own contribution to the end result.